03:55 AM EDT, 05/07/2025 (MT Newswires) -- PTC Therapeutics ( PTCT ) reported Q1 net income late Tuesday of $10.04 per diluted share, swinging from a loss of $1.20 a year earlier.
Revenue for the quarter ended March 31 was $1.18 billion, up from $210.1 million a year earlier.
Shares of the company were up 5% in Tuesday's after-hours activity.